Molbio Diagnostics' initial public offering (IPO) allotment was finalised on August 13, following an oversubscription of 70.26 times. Investors who applied for shares can check their allotment status through Kfin Technologies. The IPO is set to debut on the stock market on August 17, with a current grey market premium of ₹156 indicating strong investor interest, according to livemint.com.
The IPO process saw significant demand, with the company receiving bids far exceeding the number of shares offered. The allotment finalisation marks the completion of the subscription phase, enabling investors to confirm their share allocations. The grey market premium suggests positive market sentiment ahead of the listing. Investors can verify their allotment status on the official platform provided by Kfin Technologies, as detailed by livemint.com.
Molbio Diagnostics' IPO performance reflects robust investor appetite in the healthcare diagnostics sector. The oversubscription level of over 70 times places it among the highly subscribed public offerings in recent times. The ₹156 grey market premium signals expectations of a strong listing day, aligning with trends seen in other successful IPOs in the Indian market. This level of demand highlights the growing interest in healthcare technology companies among retail and institutional investors.
The IPO allotment finalisation on August 13 allows investors to prepare for the stock's market debut on August 17. The grey market premium of ₹156 provides a concrete indicator of anticipated listing gains. Investors can access their allotment details via Kfin Technologies, which is managing the share distribution process.